Another component of the blood clotting machinery unraveled

November 24, 1999

Insights in the molecular steps of the coagulation cascade / Relevance for cell-membrane interactions

Researchers at the Max Planck Institute for Biochemistry in Martinsried/Munich have determined the structure of an important domain of coagulation factor Va. This opens new insights into the molecular details of blood coagulation, as well as in the overall mechanisms of protein-membrane association. The results are reported in Nature 25 November 1999.

An intact circulatory system is vital for all physiological processes. Vascular injuries must be therefore rapidly sealed and repaired. This is achieved through the so-called blood coagulation cascade: several, similarly assembled proteinases (i.e., enzymes, that cleave other proteins) are stepwise specifically activated, in a cumulative domino effect. In the final step of this coagulation cascade, the proteinase thrombin is liberated into the blood stream. As a result of thrombin's activities, the soluble plasma protein fibrinogen is converted into fibrin, which spontaneously associates into insoluble polymers. Further, blood platelets are activated by thrombin, and aggregate thereupon. Fibrin and activated platelets constitute the main components of the blood clot, which seals the site of the injury.

A research group, headed by Wolfram Bode in the Department of Structural Research (Director: Prof. Robert Huber) at the Max Planck Institute for Biochemistry in Martinsried/Germany, has solved in the last decade the X-ray structures of thrombin and several inhibitor complexes, as well as other coagulation proteinases (factors IXa and Xa). These results have improved our understanding of the molecular processes leading to blood clotting. On the other hand, the structures of the non-enzymatic cofactors Va and VIIIa were up to now elusive, and therefore their mechanism of membrane association only poorly understood. Investigations conducted at the Duke University (Durham/North Carolina) have shown that the C-terminal domain of factor Va is essential for membrane attachment. This process is highly stereospecific, i.e. it relies on the recognition of phospholipid head groups that possess the amino acid L-serine, not its mirror image.

Pablo Fuentes-Prior and Sandra Macedo-Ribeiro of Wofram Bode's group have solved, in collaboration with William Kane (Duke University), the crystal structures of this membrane binding domain of coagulation factor Va in two different crystal forms (see Figure). The now unraveled domain possesses a barrel-like shape, from which three major loops protrude. These loops either cover ("closed form") or disclose ("open form") a cavity suitable for accommodation of a negatively charged phospholipid head group. The researchers propose that interaction with a few phospholipid head groups in the "closed form" promotes conformational changes leading to the unfolding of the loops and the exposure of this major cavity. The loops can then insert into the interior of the membrane, helped by favorable electrostatic interactions between the negatively charged phospholipid head groups and basic amino acid residues located at the barrel surface.

The results of this structural analysis are relevant not only for the mechanism of blood clotting, but also for several other proteins involved in cell-cell and cell-membrane interactions. Only to mention one example: there are neuroreceptors (neuropilins), which possess similar domains and regulate the axon growth. Further, it is known that mutations in this functional unit are responsible for genetic diseases such as the X-linked juvenile retinoschisis. The determination of such a crucial structure constitutes therefore the basis for further investigations, in particular for mutagenesis studies.
-end-
Published: 25-11-99
Contact: Pablo Fuentes-Prior
Max Planck Institute for Biochemistry,
Martinsried/Germany
E-Mail: fuentes@biochem.mpg.de
Phone: (+49 89) 8578-2729
Fax: (+49 89) 8578-3516


Max-Planck-Gesellschaft

Related Amino Acid Articles from Brightsurf:

Model for acid-tolerant yeast helps guide industrial organic acid production
Microbes and other microscopic organisms could serve as sustainable ''factories'' to create many types of industrial materials because they naturally convert nutrients such as sugars into byproducts.

Igniting the synthetic transport of amino acids in living cells
Researchers from ICIQ's Ballester group and IRBBarcelona's Palacín group have published a paper in Chem showing how a synthetic carrier calix[4]pyrrole cavitand can transport amino acids across liposome and cell membranes bringing future therapies a step closer.

Scientists found a connection between amino acid metabolism and joint hypermobility in autistic children
A team of researchers found out that children with autistic spectrum disorder (ASD) have increased levels of the amino acid hydroxyproline.

Microwaves are useful to combine amino acids with hetero-steroids
Aza-steroids are important class of compounds because of their numerous biological activities.

Prediction of protein disorder from amino acid sequence
Structural disorder is vital for proteins' function in diverse biological processes.

A natural amino acid could be a novel treatment for polyglutamine diseases
Researchers from Osaka University, National Center of Neurology and Psychiatry, and Niigata University identified the amino acid arginine as a potential disease-modifying drug for polyglutamine diseases, including familial spinocerebellar ataxia and Huntington disease.

Alzheimer's: Can an amino acid help to restore memories?
Scientists at the Laboratoire des Maladies Neurodégénératives (CNRS/CEA/Université Paris-Saclay) and the Neurocentre Magendie (INSERM/Université de Bordeaux) have just shown that a metabolic pathway plays a determining role in Alzheimer's disease's memory problems.

Supplementing diet with amino acid successfully staves off signs of ALS in pre-clinical study
The addition of dietary L-serine, a naturally occurring amino acid necessary for formation of proteins and nerve cells, delayed signs of amyotrophic lateral sclerosis (ALS) in an animal study.

New study indicates amino acid may be useful in treating ALS
A naturally occurring amino acid is gaining attention as a possible treatment for ALS following a new study published in the Journal of Neuropathology & Experimental Neurology.

Breaking up amino acids with radiation
A new experimental and theoretical study published in EPJ D has shown how the ions formed when electrons collide with one amino acid, glutamine, differ according to the energy of the colliding electrons.

Read More: Amino Acid News and Amino Acid Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.